CATABASIS PHARMACEUTICALS INC Contracts & Agreements

Second Amended and Restated 2015 Stock Incentive Plan, as amended (Filed With SEC on August 12, 2024)

License Agreement, dated as of October 4, 2023, by and between Ichnos Sciences SA, Ichnos Sciences Inc. and the Registrant (Filed With SEC on March 4, 2024)

Open Market Sale AgreementSM, dated as of March 4, 2024, by and between the Company and Jefferies LLC (Filed With SEC on March 4, 2024)

Underwriting Agreement, dated January 30, 2024, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C (Filed With SEC on January 31, 2024)

Underwriting Agreement, dated October 11, 2023, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C (Filed With SEC on October 12, 2023)

Form of Pre-Funded Warrant (Filed With SEC on October 12, 2023)

Form of Common Stock Warrant (Filed With SEC on October 12, 2023)

Master Consulting Agreement between the Registrant and Joanne Beck dated as of April 3, 2023 with Statement of Work No. 1 thereto dated as of April 3, 2023 and Statement of Work... (Filed With SEC on August 7, 2023)

Amended and Restated 2015 Stock Incentive Plan, as amended (Filed With SEC on August 7, 2023)

Underwriting Agreement, dated December 15, 2022, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C (Filed With SEC on December 15, 2022)

Amended and Restated Executive Severance Benefits Plan effective October 7, 2020 (Filed With SEC on May 12, 2022)

Form of Incentive Stock Option Agreement under 2015 Stock Incentive Plan (Filed With SEC on May 12, 2022)

Form of Nonstatutory Stock Option Agreement under 2015 Stock Incentive Plan (Filed With SEC on May 12, 2022)

2015 Employee Stock Purchase Plan (Filed With SEC on May 12, 2022)

Description of Registered Securities (Filed With SEC on March 10, 2022)

Open Market Sale AgreementSM, dated as of June 30, 2021, by and between the Company and Jefferies LLC (Filed With SEC on June 30, 2021)

Warrant to Purchase Shares of Series X Preferred Stock issued on January 28, 2021 to Viridian LLC (Filed With SEC on March 11, 2021)

Warrant to Purchase Shares of Common Stock issued on January 28, 2021 to Viridian LLC (Filed With SEC on March 11, 2021)

Registration Rights Agreement, dated as of January 28, 2021, by and among the Registrant and each purchaser identified therein (Filed With SEC on March 11, 2021)

Form of Registration Rights Agreement, by and among Catabasis Pharmaceuticals, Inc. and certain purchasers named therein (Filed With SEC on January 29, 2021)

Stock Purchase Agreement, dated as of January 28, 2021, by and among Catabasis Pharmaceuticals, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on January 29, 2021)

Agreement and Plan of Merger, dated January 28, 2021, by and among Catabasis Pharmaceuticals, Inc., Cabo Merger Sub I, Inc., Cabo Merger Sub II, LLC and Quellis Biosciences, Inc (Filed With SEC on January 29, 2021)

Catabasis Pharmaceuticals, Inc. Amended and Restated Executive Severance Benefits Plan, effective October 7, 2020 (Filed With SEC on November 12, 2020)

Description of Registered Securities (Filed With SEC on March 10, 2020)

Underwriting Agreement, dated January 30, 2020, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on January 30, 2020)

Sublease Agreement, dated as of September 9, 2019, by and between Allied Minds, LLC and the Registrant (Filed With SEC on November 7, 2019)

Form of Warrant (Filed With SEC on February 6, 2019)

Underwriting Agreement, dated February 6, 2019, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on February 6, 2019)

Sales Agreement, dated as of November 13, 2018, by and between the Company and Cowen and Company, LLC (Filed With SEC on November 13, 2018)

Underwriting Agreement, dated June 19, 2018, by and between the Company and the Underwriter (Filed With SEC on June 20, 2018)

Form of Common Warrant (Filed With SEC on June 20, 2018)

Form of Warrant (Filed With SEC on June 15, 2018)

Form of Underwriting Agreement (Filed With SEC on June 12, 2018)

Form of Pre-Funded Warrant (Filed With SEC on June 12, 2018)

Form of Warrant (Filed With SEC on June 12, 2018)

Sales Agreement, dated as of October 13, 2017, by and between the Company and Cowen and Company, LLC (Filed With SEC on October 13, 2017)

FOURTH AMENDMENT OF LEASE (Filed With SEC on August 10, 2017)

Catabasis Pharmaceuticals, Inc. 2,500,000 Shares Common Stock ($0.001 par value per share) Underwriting Agreement (Filed With SEC on September 23, 2016)

CATABASIS PHARMACEUTICALS, INC. $10,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on August 11, 2016)

SUMMARY OF NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (updated April 5, 2016) (Filed With SEC on May 12, 2016)

CONSULTING AGREEMENT (Filed With SEC on April 1, 2016)

Exhibit A Payments Subject to Section 409A (Filed With SEC on March 15, 2016)

SECOND AMENDMENT TO CREDIT AND SECURITY AGREEMENT (Filed With SEC on March 15, 2016)

SUMMARY OF NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (adopted February 11, 2016) (Filed With SEC on March 15, 2016)

CATABASIS PHARMACEUTICALS, INC. 2015 STOCK INCENTIVE PLAN (Filed With SEC on June 11, 2015)

Catabasis Pharmaceuticals, Inc. Shares Common Stock ($0.001 par value per share) Underwriting Agreement (Filed With SEC on June 11, 2015)

CATABASIS PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on June 11, 2015)

CATABASIS PHARMACEUTICALS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 3, 2015)

CATABASIS PHARMACEUTICALS, INC. NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on June 3, 2015)

CATABASIS PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on June 3, 2015)

CATABASIS PHARMACEUTICALS, INC. 2015 STOCK INCENTIVE PLAN (Filed With SEC on June 3, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 13, 2015)

INDEMNIFICATION AGREEMENT (Filed With SEC on May 13, 2015)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 13, 2015)

CATABASIS PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on May 13, 2015)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 13, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 13, 2015)

CATABASIS PHARMACEUTICALS, INC. Nonstatutory Stock Option Agreement Granted Under 2008 Equity Incentive Plan (Filed With SEC on May 13, 2015)

CATABASIS PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2008 Equity Incentive Plan (Filed With SEC on May 13, 2015)

CATABASIS PHARMACEUTICALS, INC. AMENDED AND RESTATED 2008 EQUITY INCENTIVE PLAN (Filed With SEC on May 13, 2015)

Category

Industry

Companies

Contracts

CATABASIS PHARMACEUTICALS INC Contracts & Agreements